Table 2. Baseline characteristics, univariate and multivariate analysis of factors associated with mortality and loss to follow up after antiretroviral therapy initiation.
| Mortality | Loss to follow up | ||||
|---|---|---|---|---|---|
| N (%) | SHR | aSHR | SHR | aSHR | |
| Age (years) | |||||
| 0–1 | 45 (16.01) | 1 (Reference) | 1 (Reference) | 1 (Reference) | 1 (Reference) |
| 2–4 | 61 (21.71) | 0.45 (0.14–1.43) | 1.52 (0.28–8.28) | 1.03 (0.34–3.10) | 0.98 (0.21–4.56) |
| 5–9 | 99 (35.23) | 0.18* (0.05–0.72) | 0.73 (0.11–5.11) | 0.94 (0.32–2.77) | 1.33 (0.29–5.98) |
| >=10 | 76 (27.05) | 1.01 (0.38–2.69) | 5.30* (1.15–24.48) | 0.65 (0.18–2.27) | 0.93 (0.16–5.32) |
| Gender | |||||
| Female | 131 (46.62) | 0.83 (0.38–1.80) | 0.91 (0.37–2.24) | 0.62 (0.29–1.34) | 0.66 (0.27–1.60) |
| Male | 150 (53.38) | 1 (Reference) | 1 (Reference) | 1 (Reference) | 1 (Reference) |
| Community | |||||
| OC | 67 (23.84) | 0.99 (0.38–2.62) | 0.67 (0.23–1.97) | 0.65 (0.24–1.75) | 0.82 (0.29–2.37) |
| BC | 149 (53.02) | 1 (Reference) | 1 (Reference) | 1 (Reference) | 1 (Reference) |
| SC | 57 (20.28) | 1.46 (0.57–3.72) | 0.85 (0.21–3.49) | 1.18 (0.49–2.86) | 1.13 (0.32–4.05) |
| ST | 8 (2.85) | 1.27 (0.18–8.76) | 0.67 (0.12–3.85) | 1.00 (0.12–8.36) | 1.07 (0.09–13.25) |
| Living near a town | |||||
| No | 181 (64.41) | 1 (Reference) | 1 (Reference) | 1 (Reference) | 1 (Reference) |
| Yes | 100 (35.59) | 1.24 (0.56–2.73) | 1.09 (0.37–3.20) | 1.07 (0.50–2.30) | 1.52 (0.61–3.77) |
| Distance to hospital | |||||
| <30 min | 72 (25.62) | 1 (Reference) | 1 (Reference) | 1 (Reference) | 1 (Reference) |
| 30–59 min | 55 (19.57) | 1.93 (0.68–5.46) | 2.55 (0.71–9.14) | 0.75 (0.18–3.17) | 1.04 (0.22–4.82) |
| 60–90 min | 62 (22.06) | 1.23 (0.39–3.83) | 0.84 (0.19–3.79) | 0.51 (0.10–2.61) | 0.71 (0.12–4.27) |
| >90 min | 92 (32.74) | 0.64 (0.19–2.13) | 0.82 (0.20–3.26) | 3.17* (1.21–8.30) | 5.07* (1.80–14.25) |
| Year of ART | |||||
| 2007 | 36 (12.81) | 0.93 (0.08–11.20) | 0.62 (0.03–12.75) | 0.31 (0.08–1.17) | 0.38 (0.07–2.07) |
| 2008 | 44 (15.66) | 3.53 (0.41–30.52) | 5.04 (0.43–58.87) | 0.42 (0.11–1.64) | 0.62 (0.12–3.17) |
| 2009 | 54 (19.22) | 2.26 (0.25–20.47) | 2.64 (0.19–36.41) | 0.61 (0.17–2.13) | 0.77 (0.14–4.31) |
| 2010 | 59 (21) | 2.59 (0.28–23.54) | 2.90 (0.18–46.20) | 0.47 (0.13–1.69) | 0.65 (0.14–3.12) |
| 2011 | 39 (13.88) | 3.17 (0.32–31.12) | 2.60 (0.13–51.85) | 0.33 (0.06–1.81) | 0.40 (0.05–3.08) |
| 2012 | 49 (17.44) | 1 (Reference) | 1 (Reference) | 1 (Reference) | 1 (Reference) |
| Status of parents | |||||
| Alive, rented house | 73 (25.98) | 1 (Reference) | 1 (Reference) | 1 (Reference) | 1 (Reference) |
| Alive, owned house | 60 (21.35) | 1.49 (0.50–4.43) | 0.89 (0.23–3.47) | 2.27 (0.86–5.96) | 2.38 (0.87–6.52) |
| Father died | 73 (25.98) | 0.83 (0.25–2.76) | 0.62 (0.11–3.37) | 1.03 (0.33–3.18) | 1.13 (0.32–3.96) |
| Mother died | 29 (10.32) | 0.39 (0.05–3.19) | 0.50 (0.06–4.53) | 0.41 (0.05–3.38) | 0.34 (0.04–2.89) |
| Both died | 46 (16.37) | 1.81 (0.61–5.39) | 1.72 (0.34–8.76) | 1.29 (0.40–4.16) | 0.83 (0.20–3.35) |
| Pre–ART care | |||||
| <3 months | 152 (54.48) | 1 (Reference) | 1 (Reference) | 1 (Reference) | 1 (Reference) |
| >3 months | 127 (45.52) | 0.42 (0.17–1.07) | 0.36* (0.13–0.96) | 0.44 (0.18–1.04) | 0.42 (0.15–1.21) |
| 12-month AIDS risk (%) | 4.9 (3.4–12.5)** | 1.04* (1.02–1.06) | 1.04* (1.01–1.08) | 1.00 (0.98–1.03) | 1.00 (0.97–1.04) |
Notes.
*
P-value <0.05
**
median (interquartile range).
- aSHR
- adjusted sub-distribution hazard ratio
- ART
- antiretroviral therapy
- BC
- backward castes
- CI
- confidence interval
- N
- number
- OC
- other castes
- SHR
- sub-distribution hazard ratio
- SC
- scheduled castes
- ST
- scheduled tribes